Related Experiment Video
Updated: Aug 9, 2026

05:44
Ultrasonographic Evaluation of Breast Cancer-related Lymphedema
Published on: January 12, 2017
The current evaluation of nonpalpable breast lesions
N P Lang1, G E Talbert, K B Shewmake
1UAMS, Department of Surgery, Little Rock 72205.
Archives of Surgery (Chicago, Ill. : 1960)
|December 1, 1987
Summary
Needle-localized biopsies for suspected cancer can have low yields. New guidelines focusing on specific mammographic findings like clustered calcifications and dominant masses improved positive biopsy rates.
Area of Science:
- Radiology
- Oncology
- Pathology
Background:
- Needle-localized biopsies are used to evaluate suspicious mammographic findings.
- Previous studies suggested a low yield of malignant neoplasms from these biopsies.
- Optimizing biopsy selection is crucial for efficient cancer diagnosis.
Purpose of the Study:
- To evaluate the diagnostic yield of needle-localized biopsies.
- To develop evidence-based guidelines for improving biopsy selection.
- To assess the impact of revised guidelines on positive biopsy rates.
Main Methods:
- Retrospective review of 122 needle-localized biopsies performed between January 1985 and November 1986.
- Analysis of initial positive biopsy rates at two medical centers.
- Development and implementation of new biopsy guidelines.
- Prospective evaluation of biopsy rates after guideline implementation.
Main Results:
- Initial positive biopsy rates were 3.5% and 10.6% at the two centers.
- Developed guidelines excluded biopsies for low-density masses <1 cm, asymmetric densities, questionable masses, and secondary signs of malignancy.
- Biopsies were indicated for clustered calcifications, dominant masses >1 cm, stellate lesions, and interval changes.
- Implementation of guidelines led to a positive biopsy rate of 15% from November 1986 to April 1987.
Conclusions:
- Strict adherence to specific mammographic findings can significantly increase the positive yield of needle-localized biopsies.
- Revised guidelines help differentiate benign from potentially malignant lesions, reducing unnecessary invasive procedures.
- Improved selection criteria enhance diagnostic accuracy and resource allocation in breast cancer screening.

